Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.
Memorial Sloan Kettering Cancer Center has announced that Oren Cahlon, MD, a renowned radiation oncologist and expert in proton therapy, will assume the position of Associate Deputy Physician-in-Chief for the Memorial Sloan Kettering Regional Care Network. With this appointment, which is effective immediately, Dr. Cahlon will help oversee the network’s outpatient clinical programs, which span seven locations across New York and New Jersey.
Memorial Sloan Kettering Cancer Center (MSK) researchers presented the results of a randomized phase III trial at today’s press program for the European Society for Medical Oncology’s 2018 Congress in Munich, Germany. The results demonstrated that a combination of the immune checkpoint blocker avelumab (Bavencio®) and the tyrosine kinase inhibitor (TKI) axitinib (Inlyta®) can significantly improve progression-free survival (PFS) in people who have been previously untreated for advanced renal cell carcinoma (RCC).
Whole breast radiation (WBRT) significantly reduced local recurrence in women with “good risk” (low risk) ductal carcinoma in situ (DCIS) following breast conservation surgery, according to researchers from Memorial Sloan Kettering Cancer Center, who presented this data in a press conference at the annual meeting of the American Society for Radiation Oncology (ASTRO).
The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD, Chair of the Department of Radiology, a recipient of the David Rall Medal. The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak received the award at the 2018 NAM Annual Meeting on Monday, October 15, 2018, in Washington, D.C.
Sam Bakhoum, MD, PhD, Assistant Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK), has been named a winner of the 2018 National Institutes of Health Director’s Early Independence Award, which is provided by the NIH Common Fund’s High-Risk, High-Reward Research program. This award is given to exceptional scientists who have contributed significant work in biomedical research.
Memorial Sloan Kettering shares results of a recent review by our Boards of Overseers and Managers, as well as additional policies we are considering to enhance communication, transparency, disclosure, and oversight of outside activities and industry-supported clinical trials.
Today Memorial Sloan Kettering (MSK) announced the appointment of a task force that will assess MSK policies and processes for reporting and managing outside activities and industry-supported clinical trials.
The Ralph Lauren Center for Cancer Care, a Harlem-based cancer prevention and treatment program, is expected to more closely align with Memorial Sloan Kettering Cancer Center (MSK) in 2019 pending the approval of the New York State Department of Health and other state agencies. The filing deepens the longstanding partnership between MSK and the Ralph Lauren Center.